PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 31 filers reported holding PHARMACYTE BIOTECH INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 92,087 | $193,383 | 1.31% |
| SABBY MANAGEMENT, LLC | 97,124 | $203,960 | 0.15% |
| K2 PRINCIPAL FUND, L.P. | 258,481 | $542,810 | 0.11% |
| EQUITEC PROPRIETARY MARKETS, LLC | 82,727 | $173,727 | 0.04% |
| CSS LLC/IL | 13,186 | $27,691 | 0.00% |
| Aspire Private Capital, LLC | 800 | $1,680 | 0.00% |
| Schonfeld Strategic Advisors LLC | 23,300 | $48,930 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,971 | $4,139 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 29,307 | $61,545 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 116 | $243 | 0.00% |
| WELLS FARGO & COMPANY/MN | 53 | $111 | 0.00% |
| NORTHERN TRUST CORP | 19,283 | $40,494 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 219,110 | $460,158 | 0.00% |
| MORGAN STANLEY | 3 | $8 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 7,126 | $14 | 0.00% |
| BlackRock Inc. | 41,713 | $87,597 | 0.00% |
| Bank of New York Mellon Corp | 16,593 | $34,845 | 0.00% |
| Citadel Advisors | 3,400 | $7,140 | 0.00% |
| Citadel Advisors | 1,600 | $3,360 | 0.00% |
External links
This page lists PHARMACYTE BIOTECH INC's shareholders in Q3 2023. To view PHARMACYTE BIOTECH INC's shareholder history, click here.